Anti-Chlamydia trachomatis, W4 Protein, aa191-286, Recombinant
Immunoreactive with sera from Chlamydia trachomatis W4 infected individuals with minimum specificity problems.
Source
Recombinant protein corresponding to MOMP immunodominant region aa191-286 of Chlamydia trachomatis W4, fused to 6x-His at C-terminal, expressed in E. coli.
Applications
Suitable for use in ELISA, Western Blot, Flow-through. Other applications not tested.
Recommended Dilution
Optimal dilutions to be determined by the researcher.
Storage and Stability
Aliquot to avoid repeated freezing and thawing and store at -70°C. Aliquots are stable for 6 months after receipt. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
Source
Recombinant, E. coli
Form
Supplied as a liquid in 1.5M Urea, 20mM Tris-HCLl, pH 7.2, 50% glycerol.
Important Note
This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.
Form
Supplied as a liquid in 1.5M Urea, 20mM Tris-HCLl, pH 7.2, 50% glycerol.
